tiprankstipranks
Oncology Pharma (ONPH)
OTHER OTC:ONPH
US Market
ONPH
Oncology Pharma
RESEARCH TOOLSreports
Want to see ONPH full AI Analyst Report?

Oncology Pharma (ONPH) Income Statement

169 Followers

Oncology Pharma Income Statement

Last quarter (Q3 2022), Oncology Pharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Oncology Pharma's net income was $-254.88K. See Oncology Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -779.00$ -1.11K$ -1.11K
Operating Expenses
$ 62.05K$ 14.41M$ 402.77K$ 817.75K
Depreciation and Amortization
$ 236.56K$ 779.00$ 1.11K$ 1.11K
EBITDA
$ 228.68K$ -14.66M$ -181.45K$ -817.75K
Operating Income
$ -62.05K$ -14.41M$ -403.88K$ -818.86K
Other Income/Expenses
$ -104.56M$ -83.06M$ 196.33K$ -31.53K
Pretax Income
$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Net Income
$ -104.63M$ -97.47M$ -207.56K$ -850.40K
Per Share Metrics
Basic EPS
$ -3.42$ -6.76$ -0.12$ -0.72
Diluted EPS
$ -3.42$ -6.76$ -0.12$ -0.72
Weighted Average Shares Outstanding
 30.55M 14.42M 1.68M 1.19M
Weighted Average Shares Outstanding (Diluted)
 30.55M 14.42M 1.68M 1.19M
Currency in USD

Oncology Pharma Earnings and Revenue History